NCT05045677

Brief Summary

Suicidality (ideation about taking one's life, suicide plans, and attempts) is a major public health concern in Ontario and worldwide. Psychiatric inpatients with suicidality represent a group that is high-risk for subsequent suicide. Current standard-care for suicidal psychiatric inpatients focuses on containment of risk and indirect treatment of suicidality by treating any underlying mental disorder. Though there is evidence that addressing suicidality directly is more effective than an indirect approach, there are limited evidence based treatments that target suicidality. Furthermore, there are few high-quality studies that have included inpatients. Psychotherapeutic interventions are under-utilized for inpatients and COVID-19 has further widened this gap given attempts by hospitals to reduce face-to-face contact with patients. Digital psychotherapy interventions have the ability to bridge this gap given their lower cost, ease of dissemination, acceptability by patients, and effectiveness. To our knowledge, there are no studies that have assessed the feasibility, acceptability and effectiveness of digital interventions for suicidal inpatients. Our study is a feasibility trial of a previously studied digital Dialectical Behavioural Therapy (d-DBT) skills intervention in suicidal psychiatric inpatients. The study is a two arm randomized parallel group-controlled trial, 6-10 day, flexible timeline, randomized feasibility trial of a d-DBT skills intervention added to standard care for patients admitted to psychiatric inpatient units with suicidality. There will be 20 patients who will receive the intervention in addition to standard care and 20 patients who will receive standard care alone. There will also be a 4 week follow-up after discharge from hospital. Participants will be admitted for psychiatric care at the Complex and Critical Care Units, Centre for Addiction and Mental Health (CAMH), Toronto.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 16, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

September 14, 2023

Status Verified

September 1, 2023

Enrollment Period

7 months

First QC Date

August 9, 2021

Last Update Submit

September 13, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Recruitment and retention rates

    Feasibility - whether the intervention is possible in the acute inpatient setting

    6-10 days

  • Client Satisfaction Questionnaire 8 (CSQ-8)

    Acceptability - whether the intervention is appropriate for the acute inpatient setting. The CSQ-8 scores range from 8 to 32, with higher values indicating higher satisfaction with the intervention.

    6-10 days

  • User Experience Questionnaire (UXQ)

    Usability - whether the intervention is serviceable for its intended purpose. The UXQ has 11 items exploring characteristics informing usability of mobile apps, each scored from 0-10, for a total score ranging from 10-110 (with larger scores indicating increased usability).

    6-10 days

Secondary Outcomes (4)

  • Columbia-Suicide Severity Rating Scale (C-SSRS)

    5-10 days in addition to discharge and 4 weeks post-discharge

  • Clinical Global Impression (CGI)

    5-10 days in addition to discharge and 4 weeks post-discharge

  • Brief Difficulties in Emotion Regulation Scale (DERS-16)

    5-10 days in addition to discharge and 4 weeks post-discharge

  • Kessler psychological distress scale (K10)

    5-10 days in addition to discharge and 4 weeks post-discharge

Study Arms (2)

Digital DBT intervention group

EXPERIMENTAL

Digital intervention group plus standard care

Other: digital DBT skills interventionOther: Standard Care

Standard care

ACTIVE COMPARATOR

Standard care alone

Other: Standard Care

Interventions

The digital intervention consists of 6 modules that will be delivered over 6 to 10 days. The modules cover mindfulness skills, emotion regulation skills and distress tolerance skills.

Digital DBT intervention group

Standard inpatient care includes a multi-disciplinary team approach including daily psychiatric review, medication management and in-person psychosocial interventions (social work, nursing).

Digital DBT intervention groupStandard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with any DSM-5 diagnosis aged 18 years and above;
  • admitted to CAMH with suicidality and a baseline BSI score of \> 6;
  • capable and willing to give informed consent;
  • anticipated length of admission is greater than 5 days;
  • deemed suitable by the primary team to take part in a psychotherapeutic intervention as part of standard care
  • Capacity to consent will be evaluated by the research staff performing the informed consent process. It will be assessed as the participant's ability to understand and appreciate the risks and benefits of taking part in the proposed study.

You may not qualify if:

  • presence of psychiatric symptoms that interfere with the ability to complete the d-DBT
  • Concurrent treatment with ECT or MST

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Addiction and Mental Health

Toronto, Ontario, M6J1h3, Canada

Location

MeSH Terms

Conditions

Suicidal Ideation

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Ishrat Husain, MD (Res)

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2021

First Posted

September 16, 2021

Study Start

April 1, 2022

Primary Completion

November 1, 2022

Study Completion

November 1, 2022

Last Updated

September 14, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations